Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-005936

Chief Executive Officer sold 19,300 shares at an average $35.26 ($680,534)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-01-25 Sale −1,400 $33.22 $46,508 309,578 I
Ciechanover Isaac E. Chief Executive Officer 2018-01-25 Sale −8,400 $34.23 $287,532 301,178 I
Ciechanover Isaac E. Chief Executive Officer 2018-01-25 Sale −200 $34.68 $6,936 300,978 I
Ciechanover Isaac E. Chief Executive Officer 2018-01-26 Sale −1,100 $35.46 $39,006 299,878 I
Ciechanover Isaac E. Chief Executive Officer 2018-01-26 Sale −6,100 $36.54 $222,894 293,778 I
Ciechanover Isaac E. Chief Executive Officer 2018-01-26 Sale −2,100 $36.98 $77,658 291,678 I
Open-market sales · 19,300 sh · avg $35.26 · $680,534
Loading xslF345X03/doc4.xml…